Related Experiment Video
Updated: Sep 20, 2025
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Vascular Cognitive Impairment and Dementia
Insights
Vascular cognitive impairment and dementia (VCID) management focuses on controlling cardiovascular risk factors and optimizing treatment for cerebrovascular diseases. Early diagnosis through clinical evaluation and neuroimaging is crucial for effective intervention and prevention.
Area of Science:
- Neurology
- Geriatrics
- Public Health
Background:
- Vascular cognitive impairment and dementia (VCID) is a significant cause of cognitive decline, distinct from degenerative dementias.
- Understanding the diverse pathophysiology of VCID, including various cerebrovascular diseases, is essential for effective management.
- VCID represents the leading nondegenerative cause of dementia, highlighting the importance of preventative strategies.
Purpose of the Study:
- To provide a comprehensive overview of vascular cognitive impairment and dementia (VCID).
- To discuss epidemiology, pathophysiology, clinical approaches, and management strategies for VCID.
- To emphasize the role of understanding cerebrovascular diseases and managing risk factors in VCID.
Main Methods:
- Review of current literature on vascular cognitive impairment and dementia.
- Analysis of diagnostic criteria and phenotypic categories for vascular dementia.
- Examination of risk factor management and therapeutic interventions for VCID.
Main Results:
- VCID pathophysiology is heterogeneous, with diagnostic criteria categorizing it into four main phenotypes.
- Control of cardiovascular risk factors (blood pressure, cholesterol, blood sugar) is key for VCID prevention.
- Cerebral amyloid angiopathy requires specific risk factor management due to hemorrhage risk.
- Cognitive rehabilitation shows promise in improving global cognitive function in VCID patients.
Conclusions:
- Diagnosis relies on thorough clinical evaluation and neuroimaging.
- Optimizing management of identified risk factors is paramount for preventing and managing VCID.
- Symptomatic management and secondary prevention are crucial after vascular brain injury.
Purpose Of Review:
This article gives a broad overview of vascular cognitive impairment and dementia, including epidemiology, pathophysiology, clinical approach, and management. Emphasis is placed on understanding the common underlying types of cerebrovascular disease (including atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy) and awareness of rare inherited cerebrovascular disorders.
Recent Findings:
The pathophysiology of vascular cognitive impairment and dementia is heterogeneous, and the most recent diagnostic criteria for vascular cognitive impairment and dementia break down the diagnosis of major vascular dementia into four phenotypic categories, including subcortical ischemic vascular dementia, poststroke dementia, multi-infarct dementia, and mixed dementia. Control of cardiovascular risk factors, including management of midlife blood pressure, cholesterol, and blood sugars, remains the mainstay of prevention for vascular cognitive impairment and dementia. Cerebral amyloid angiopathy requires special consideration when it comes to risk factor management given the increased risk of spontaneous intracerebral hemorrhage. Recent trials suggest some improvement in global cognitive function in patients with vascular cognitive impairment and dementia with targeted cognitive rehabilitation.
Summary:
Thorough clinical evaluation and neuroimaging form the basis for diagnosis. As vascular cognitive impairment and dementia is the leading nondegenerative cause of dementia, identifying risk factors and optimizing their management is paramount. Once vascular brain injury has occurred, symptomatic management should be offered and secondary prevention pursued.
Related Concept Videos
01:30Dementia
The progression of dementia is generally gradual....
01:30Cognitive Development During Adulthood
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:22Alzheimer's Disease: Treatment